Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease

Bone Marrow Transplantation

Volumn 19, Issue 11, 1997, Pages 1111-1116

  Krause, H ^a   Hebart, H ^a   Jahn, G ^b   Muller C A ^a   Einsele, H ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

CMV infection; Late onset CMV disease; T cell proliferation

Indexed keywords

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DONOR; FEMALE; HELPER CELL; HIGH RISK PATIENT; HISTOCOMPATIBILITY; HUMAN; LYMPHOCYTE PROLIFERATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING; T LYMPHOCYTE; VIRUS CULTURE;

EID: 0030993182     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700801     Document Type: Article

References (28)

1. Meyers JD, Flournoy N, Thomas E. Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. J Infect Dis 1980; 142: 816-824.
2. Quinnan GV, Kirmani N, Rook AH et al. HLA-restricted T lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone marrow transplant recipients. New Engl J Med 1982; 307: 7-13.
3. Ljungman P, Lönnqvist B, Wahren B et al. Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients - a 1 year follow-up. Transplantation 1985; 40: 515-520.
4. Reusser P, Riddell S, Meyers J, Greenberg P. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78: 1373-1380.
5. Einsele H, Ehninger G, Steidle M et al. Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood 1993; 82: 1672-1678.
6. Fries BC, Khaira D, Pepe MS, Torok-Storb B. Declining lymphocyte counts following cytomegalovirus (CMV) infection are associated with fatal CMV disease in bone marrow transplant patients. Exp Hematol 1993; 21: 1387-1392.
7. Li CR, Greenberg PD, Gilbert MJ et al. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994; 83: 1971-1979.
8. Einsele H, Ehninger G, Hebart H et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side-effects of antiviral therapy after bone marrow transplantation. Blood 1995; 86: 2815-2820.
9. Bowden RA, Digel J, Reed EC, Meyers JD. Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses. J Infect Dis 1987; 156: 899-903.
10. Atkinson K, Arthur C, Bradstock K et al. Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune suppressed HLA-identical unrelated donor marrow transplant recipients. Bone Marrow Transplant 1995; 16: 401-405.
11. Ljungman P, Griffiths P. Definitions of cytomegalovirus infection and disease. In: Michelson S, Plotkin SA (eds). Multi-disciplinary Approach to Understanding Cytomegalovirus Disease. Elsevier Science: Paris, 1993, pp. 233-237.
12. Einsele H, Steidle M, Vallbracht A et al. Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood 1991; 77: 1104-1110.
13. Einsele H, Ehninger G, Steidle M et al. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet 1991; ii: 1170-1172.
14. Waner JL, Budnick JE. Blastogenic response of human lymphocytes to human cytomegalovirus. Clin Exp Immunol 1977; 30: 44-49.
15. Wahren B, Ljungman P, Paulin T, Ringden O. Enhansive and suppressive effects of cytomegalovirus on human lymphocyte responses in vitro. J Virol 1986; 58: 909-913.
16. Gehrz RC, Peterson ES, Liu YN. Immune mechanisms in congenital cytomegalovirus infection: activation of CMV-specific T helper cells (CMV-Th) by exogenous IL-2. Clin Exp Immunol 1988; 74: 333-338.
17. Boland GJ, Vlieger AM, Ververs C, De Gast GC. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation. Clin Exp Immunol 1992; 88: 506-511.
18. van Tiel FH, Rasmussen L, Merigan TC. Cytomegalovirus-specific cell-mediated immune responses in heart and heart-lung transplant recipients are not predictive for the occurrence of symptomatic CMV disease or tissue rejection. J Interferon Res 1991; 11: 221-229.
19. Lindsley MD, Torpey III DJ, Rinaldo Jr CR. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells. J Immunol 1986; 136: 3045-3051.
20. Reddehase MJ, Mutter W, Munch K et al. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 1987; 61: 3102-3108.
21. Riddell SR, Watanabe KS, Goodrich JM et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992; 257: 238-241.
22. Riddell SR, Greenberg PD. Therapeutic reconstitution of human viral immunity by adoptive transfer of cytotoxic T lymphocyte clones. Curr Top Microbiol Immunol 1994; 189: 9-34.
23. Boland GJ, Heue RJ, Ververs C et al. Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation. Clin Exp Immunol 1993; 94: 306-312.
24. Ljungman P, Aschan J, Azinge JN et al. Cytomegalovirus -viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation. Br J Hematol 1993; 83: 118-124.
25. Müller CA, Einsele H. Influence of human cytomegalovirus on immune reconstitution after bone marrow transplantation. Ann Hematol 1992; 64 (Suppl): A140-A142.
26. Reusser P, Attenhofer R, Hebart H et al. CMV-specific T-lymphocyte (CTL) activity and CMV infection and disease after autologous bone marrow or peripheral blood stem cell transplantation (Tx). The Fifth International Cytomegalovirus Conference 1995; poster No. 233.
27. Marks DI, Culis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. Ann Intern Med 1993; 119: 207-214.
28. Ochs L, Shu XO, Miller J et al. Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients. Blood 1995; 86: 3979-3986.